Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117461) titled 'Therapeutic effect of Shugan Jianpi huoxue recipe on high risk population of liver cancer in compensated stage of hepatitis B cirrhosis and key techniques of early warning of liver cancer' on Jan. 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Ditan Hospital Capital Medical University
Condition:
Liver disease
Intervention:
Control group:Placebo
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-07-01
Target Sample Size: Control group:190;TCM treatment group:190;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn...